RecruitingNCT03025074
Blood Collection Biorepository for Liver Disease Research
Virology, Immunology and Mechanisms of Liver Disease in Patients With Hepatitis C and Other Liver Diseases
Sponsor
State University of New York at Buffalo
Enrollment
1,000 participants
Start Date
Jul 1, 2013
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
Eligibility
Min Age: 7 Years
Inclusion Criteria2
- This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples.
- Children and teenagers will be special populations considered in this protocol.
Exclusion Criteria1
- Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03025074
Related Trials
Indicators Affecting PVT Recanalization
NCT074733751 location
Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis
NCT074693196 locations
FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.
NCT050957141 location
Remote Electrical Stimulation for Pain and Depression Treatment in Cirrhosis
NCT069327831 location
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
NCT012808251 location